ArticleMolecular cancer therapeutics2016

GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression.

Sandra Baumgart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.